In the ongoing trial of Khavinson peptides, Kenneth Scott recently participated by submitting both the myDNAge® Test and the Telomere Test. Khavinson peptides are derived from the research of Dr. Vladimir Khavinson and are known to mimic natural peptides found in the body. This trial aims to evaluate the efficacy of Khavinson peptides in optimizing cellular health and potentially slowing down the aging process. By undergoing the myDNAge® Test and the Telomere Test as part of the trial, Kenneth Scott’s results will contribute valuable data on the effects of Khavinson peptides on epigenetic age and telomere length, shedding light on their potential anti-aging properties.
